NFE2L2 and metabolic dysfunction-associated steatotic liver disease: These findings suggest that aberrant activation of NRF2 helps to trigger development of NASH or NAFLD, therefore, gain-of-function type mutations in NRF2 may initiate the development of HCC by inducing NASH or NAFLD.